Similarly, in the case of anxiety symptoms, since the second lockdown, the average GAD-2 score had not changed significantly (equalled 3.56–3.68), with about 33–35% of self-screened women obtaining results above the clinical cut-off point. The gene discussed is GAD1; the disease is Anxiety.